Dr. Quin Denfeld is an Associate Professor at Oregon Health and Science University in the School of Nursing and School of Medicine, Division of Cardiovascular Medicine. Dr. Denfeld’s program of research focuses on the biobehavioral mechanisms of symptoms and frailty among adults with heart failure, with a particular focus on women and older adults. She is funded by the National Institutes of Health/National Institute of Nursing Research to lead a R01 study on the biological and physiological mechanisms of symptom clusters in heart failure. She also received funding from the NIH/NINR to lead a R21 study that focuses on how physical frailty is related to self-care behaviors in heart failure. She is the Next Generation Research Co-Director for the K12 Building Interdisciplinary Research Careers in Women’s Health Program at OHSU. Outside of research, Dr. Denfeld teaches in the PhD program at the School of Nursing. She is involved in numerous professional organizations, including leading several scientific statements on symptoms, falls, and frailty, and she serves as an Associate Editor for the European Journal of Cardiovascular Nursing. Dr. Denfeld is a fellow of the American Academy of Nursing, the American Heart Association, and the Heart Failure Society of America.

Dr Jones is a specialist palliative care physician, intensivist and anaesthetist. After graduating from University of Queensland she completed postgraduate training in Queensland and Victoria, now working predominantly at TPCH in Brisbane. She has broad education and prior work experience in accounting/law as well as current studies in Masters of Medical Leadership and Management, and prior completion of Masters of Bioethics (Monash University), Masters of Critical Care Medicine (University of Sydney) and Masters of Laws (UQ). This background supports current clinical interests to improve effective communication, team management and quality and systems outcomes for patients and organisations.

John Atherton (MBBS, PhD, FRACP, FCSANZ, FHFA) is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH) and Professor, Faculty of Medicine, University of Queensland. Professor Atherton was one of four non-European official content reviewers for the 2016 European Society of Cardiology Heart Failure Guidelines and is a European Society of Cardiology Heart Failure Association Ambassador. He chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines, sits on the Therapeutic Guidelines Cardiovascular Expert Group and co-authored the first universal definition of heart failure. Professor Atherton is Data Custodian for the Queensland Cardiac Outcomes Registry (QCOR)- Heart Failure and sits as a Director on the National Cardiac Registry Board. His clinical and research interests include investigating novel methods to detect pre-symptomatic heart disease, heart failure disease management, hypertrophic cardiomyopathy and cardiac genetics.

Dr Nikki Bart is a heart failure and heart transplant cardiologist at St Vincent’s Hospital Sydney and Clinical Faculty at the Victor Chang Cardiac Research Institute.